<code id='956547E408'></code><style id='956547E408'></style>
    • <acronym id='956547E408'></acronym>
      <center id='956547E408'><center id='956547E408'><tfoot id='956547E408'></tfoot></center><abbr id='956547E408'><dir id='956547E408'><tfoot id='956547E408'></tfoot><noframes id='956547E408'>

    • <optgroup id='956547E408'><strike id='956547E408'><sup id='956547E408'></sup></strike><code id='956547E408'></code></optgroup>
        1. <b id='956547E408'><label id='956547E408'><select id='956547E408'><dt id='956547E408'><span id='956547E408'></span></dt></select></label></b><u id='956547E408'></u>
          <i id='956547E408'><strike id='956547E408'><tt id='956547E408'><pre id='956547E408'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:fashion    Page View:55515
          Hospital power in DC
          Mike Reddy for STAT

          WASHINGTON — Democrats unilaterally drove major reforms to the health insurance and the pharmaceutical industries without a single Republican vote in recent years. But hospitals may be a health care giant they’re unable to confront alone.

          Unlike Republicans, Democrats have seized on lowering health care costs as a politically winning issue in one election cycle after another. They have campaigned on passing health insurance reform, and then protecting it. And after 20 years, they finally delivered on a promise to empower the federal government to lower drug prices in 2022.

          advertisement

          But the remaining elephant in the room is hospital costs, which make up the biggest share of U.S. health care spending. And Democratic leaders in Congress have shown this year that they are unable to agree on even the most incremental steps toward addressing the cost of hospital care.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          Gritstone Bio's cancer vaccine test, and more on Novartis' deal
          Gritstone Bio's cancer vaccine test, and more on Novartis' deal

          MollyFerguson/STATThisweek,IaddresspushbackIreceivedonmyNovartis-MorphoSyscolumn.Butfirst,apreviewof

          read more
          The high cost of giving birth even with insurance
          The high cost of giving birth even with insurance

          AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

          read more

          Johnson & Johnson sued for allegedly overpaying for workers' drugs

          ChrisO'Meara/APJohnson&Johnsonfacesaconsequentialnewclassactionlawsuit—notinitsroleasamanuf